# Exagen Inc.: Form 8-K, filed Jan 8, 2024

- Company: [Exagen Inc.](/companies/xgn.md) (CIK 1274737)
- Form: 8-K
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 08:00 ET
- Period: 2024-01-07
- Accession: 0001274737-24-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000006/exdx-20240107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000006/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1274737/000127473724000006/exdx-20240107.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001274737-24-000006. Last ingested by Listed: Nov 15, 2026, 04:30 ET. No prices; not investment advice.
